Advances in Targeted Therapies for Inflammatory Diseases and Cancer: Exploring Cellular Mechanisms and Therapeutic Strategies

Abstract

Managing chronic inflammatory diseases and cancers has traditionally faced challenges due to the complexity of disease mechanisms and the often-insufficient specificity of treatments. This Patent Highlight showcases findings from three innovative patents that propose distinct yet complementary therapeutic strategies to modulate key cellular processes involved in inflammation and cancer progression. The first strategy involves proteolysis targeting chimeras (PROTACs) for the selective degradation of IRAK4, a kinase central to inflammatory signaling, the second employs lipid-binding protein complexes to modulate systemic inflammatory responses, and the third utilizes selective inhibitors targeting pathogenic epithelial stem cells to prevent the progression of metaplasia into dysplasia and cancer. Collectively, these approaches highlight a shift toward precision medicine, offering the potential for synergistic applications in clinical settings.